Norris Perne & French LLP MI Purchases New Holdings in Procter & Gamble Company (The) $PG

Norris Perne & French LLP MI purchased a new stake in Procter & Gamble Company (The) (NYSE:PG) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 7,246 shares of the company’s stock, valued at approximately $1,053,000.

Several other institutional investors have also recently made changes to their positions in PG. Signaturefd LLC raised its stake in shares of Procter & Gamble by 14.4% during the 3rd quarter. Signaturefd LLC now owns 80,702 shares of the company’s stock worth $11,724,000 after purchasing an additional 10,178 shares in the last quarter. Bond & Devick Financial Network Inc. grew its stake in shares of Procter & Gamble by 5.3% in the third quarter. Bond & Devick Financial Network Inc. now owns 7,562 shares of the company’s stock valued at $1,099,000 after buying an additional 381 shares in the last quarter. McGuire Investment Group LLC increased its holdings in Procter & Gamble by 9.3% during the third quarter. McGuire Investment Group LLC now owns 2,937 shares of the company’s stock worth $427,000 after buying an additional 250 shares during the last quarter. Simplicity Wealth LLC increased its holdings in Procter & Gamble by 3.5% during the third quarter. Simplicity Wealth LLC now owns 66,516 shares of the company’s stock worth $9,664,000 after buying an additional 2,224 shares during the last quarter. Finally, Brookmont Capital Management raised its position in Procter & Gamble by 34.4% during the third quarter. Brookmont Capital Management now owns 32,483 shares of the company’s stock worth $4,719,000 after acquiring an additional 8,309 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of PG stock opened at $161.21 on Friday. The company has a market capitalization of $374.43 billion, a price-to-earnings ratio of 24.28, a PEG ratio of 4.00 and a beta of 0.39. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.47 and a current ratio of 0.72. The company has a 50-day simple moving average of $148.41 and a 200 day simple moving average of $147.09. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $167.25.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. The business had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 30.91%. Procter & Gamble’s quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.99 EPS. On average, sell-side analysts predict that Procter & Gamble Company will post 6.98 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be issued a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s payout ratio is currently 65.51%.

Analysts Set New Price Targets

A number of analysts have commented on PG shares. HSBC reiterated a “hold” rating and issued a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a research note on Thursday, July 30th. Weiss Ratings restated a “hold (c)” rating on shares of Procter & Gamble in a research note on Monday, September 21st. JPMorgan Chase & Co. upped their target price on shares of Procter & Gamble from $162.00 to $180.00 and gave the company an “overweight” rating in a report on Friday. Citigroup lifted their price target on Procter & Gamble from $180.00 to $187.00 and gave the stock a “buy” rating in a report on Friday. Finally, Barclays boosted their price target on Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 21st. Fifteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $168.90.

Insider Buying and Selling

In other news, insider Marc Pritchard sold 4,030 shares of the stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total transaction of $579,473.70. Following the transaction, the insider owned 187,001 shares in the company, valued at approximately $26,888,873.79. This trade represents a 2.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Susan Whaley sold 2,369 shares of the stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $344,310.46. Following the transaction, the insider owned 30,730 shares in the company, valued at approximately $4,466,298.20. This trade represents a 7.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 15,135 shares of company stock valued at $2,189,970 in the last ninety days. 0.23% of the stock is currently owned by company insiders.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
• Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
• Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
• Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.